Stock Research for LXRP

LXRP

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

LXRP Stock Chart & Research Data

The LXRP chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the LXRP chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


LXRP Due diligence Resources & Stock Charts

The LXRP stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View LXRP Detailed Price Forecast - CNN Money CNN View LXRP Detailed Summary - Google Finance
Yahoo View LXRP Detailed Summary - Yahoo! Finance Zacks View LXRP Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View LXRP Trends & Analysis - Trade-Ideas Barrons View LXRP Major Holders - Barrons
NASDAQ View LXRP Call Transcripts - NASDAQ Seeking View LXRP Breaking News & Analysis - Seeking Alpha
Spotlight View LXRP Annual Report - CompanySpotlight.com OTC Report View LXRP OTC Short Report - OTCShortReport.com
TradeKing View LXRP Fundamentals - TradeKing Charts View LXRP SEC Filings - Bar Chart
WSJ View Historical Prices for LXRP - The WSJ Morningstar View Performance/Total Return for LXRP - Morningstar
MarketWatch View the Analyst Estimates for LXRP - MarketWatch CNBC View the Earnings History for LXRP - CNBC
StockMarketWatch View the LXRP Earnings - StockMarketWatch MacroAxis View LXRP Buy or Sell Recommendations - MacroAxis
Bullish View the LXRP Bullish Patterns - American Bulls Short Pains View LXRP Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View LXRP Stock Mentions - StockTwits PennyStocks View LXRP Stock Mentions - PennyStockTweets
Twitter View LXRP Stock Mentions - Twitter Invest Hub View LXRP Investment Forum News - Investor Hub
Yahoo View LXRP Stock Mentions - Yahoo! Message Board Seeking Alpha View LXRP Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for LXRP - SECform4.com Insider Cow View Insider Transactions for LXRP - Insider Cow
CNBC View LXRP Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for LXRP - OTC Markets
Yahoo View Insider Transactions for LXRP - Yahoo! Finance NASDAQ View Institutional Holdings for LXRP - NASDAQ


Stock Charts

FinViz View LXRP Stock Insight & Charts - FinViz.com StockCharts View LXRP Investment Charts - StockCharts.com
BarChart View LXRP Stock Overview & Charts - BarChart Trading View View LXRP User Generated Charts - Trading View




Latest Financial News for LXRP


Life Sciences Companies Investors Presentations Now Available for On-Demand Viewing
Posted on Monday March 30, 2020

NEW YORK, March 30, 2020 -- Life Sciences Investor Forum today announced that the presentations from its inaugural conference are now available for on-demand viewing at.


Lexaria Bioscience Corp. to Webcast Live at Life Sciences Investor Forum March 26
Posted on Tuesday March 24, 2020

Lexaria Bioscience Corp. (LXRP) (CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platform today announced that Chris Bunka, Chief Executive Officer, will present live at LifeSciencesInvestorForum.com on March 26. Investigation into its patented DehydraTECH drug delivery technology will be pursued to determine the extent of improvements possible in antiviral drug delivery designed to fight against coronavirus disease COVID-19.


Virtual Conference for Life Sciences Companies and Investors Broadcast Live March 26, 2020
Posted on Tuesday March 24, 2020

NEW YORK, March 24, 2020 -- Life Sciences Investor Forum today announced the agenda for its inaugural event for public and private companies, investors and industry.


Lexaria Bioscience Expands Pharmaceutical Division to Include Lipophilic Antiviral Active Molecules for COVID-19 Treatment
Posted on Monday March 23, 2020

KELOWNA, BRITISH COLUMBIA / ACCESSWIRE / March 23, 2020 / Lexaria Bioscience Corp. (LXRP)(LXX.CN) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, has expanded the scope and activities of its 100%-owned subsidiary Lexaria Pharmaceutical Corp., to investigate how Lexaria's patented DehydraTECHTM drug delivery technology could enhance delivery and effectiveness of certain antiviral drugs in the fight against coronavirus disease COVID-19. Lexaria intends to expand collaboration with leading laboratories in North America and internationally as soon as possible. Within the Lexaria Pharmaceutical Corp. business unit resides Intellectual Property for enhanced delivery of drugs such as non-steroidal anti-inflammatories ("NSAIDs"), vitamins, hormone treatments utilizing estrogen or testosterone and phosphodiesterase ("PDE5") inhibitors; with expansion now underway to include antiviral drugs as well.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.